A main reason for the market growth is a combination of the heightened presence of gastrointestinal disorders and the growing consumer demand for minimally invasive procedures, according to a June 28 news release from Reports and Data.
Consumers view capsule endoscopy as a safer, patient-friendly alternative, and physicians view it as a more accurate and effective way to observe the small intestine and provide treatment. Physicians are increasingly using this method to diagnose and treat gastrointestinal cancer, chronic abdominal pain, Crohn’s disease, celiac disease, excessive bleeding and ulcers, according to the report.
The second major reason for the predicted increase in market value is increased investments in research and development activities. The growing prevalence in capsule endoscopy is accelerating the rate at which companies within the market develop product innovations, create new products, establish partnerships and participate in mergers and acquisitions, according to the report.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
